ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Genetics, Genomics & Proteomics Poster

Date: Sunday, November 17, 2024

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2024

10:30AM-12:30PM
Abstract Number: 0898
A Blood Transcriptome Signature Distinguishes Between Diverse Systemic Autoimmune Diseases and Infection
10:30AM-12:30PM
Abstract Number: 0886
A Longitudinal Cohort Study Uncovers Plasma Protein Biomarkers Predating Clinical Onset and Treatment Response of Rheumatoid Arthritis
10:30AM-12:30PM
Abstract Number: 0911
Activating B Cells Facilitates the Discovery of Latent Disease-associated Variants
10:30AM-12:30PM
Abstract Number: 0915
APOH Locus Associated with Higher Anti-Beta-2-Glycoprotein 1 Antibody Levels Paradoxically Protects Against Venous Thromboembolism
10:30AM-12:30PM
Abstract Number: 0900
Association Between Serum Urate, Gout, and Prostatic Cancer in European Male Populations: A Mendelian Randomization Study
10:30AM-12:30PM
Abstract Number: 0907
Association of Rare and Common Genetic Variants in MOCOS with Inadequate Response to Allopurinol
10:30AM-12:30PM
Abstract Number: 0908
Clinical Characteristics of Patients with High SLE-specific and High Multitrait Polygenic Risk – an Investigation of SLE Risk Loci
10:30AM-12:30PM
Abstract Number: 0904
Defining the Function of Disease Variants with CRISPR Editing and Multimodal Single Cell Sequencing
10:30AM-12:30PM
Abstract Number: 0903
Distinct Impacts of Mosaic Loss of Chromosome Y and Genetic Risk on the Age of Onset in Patients with Rheumatoid Arthritis
10:30AM-12:30PM
Abstract Number: 0897
Dynamic eQTLs from Activated Human B Cells Suggest Cell-state Dependent Effects for GWAS Risk Variants in BLK
10:30AM-12:30PM
Abstract Number: 0884
Genetic Architecture Divergence in Sjögren’s Disease Subphenotypes and Populations: Genome-wide Association Study of Ro/SSA+ and Ro/SSA- Cases in European Populations
10:30AM-12:30PM
Abstract Number: 0888
Genetically Determined Peptidylglycine Alpha-amidating Monooxygenase (PAM) Mediated Amidation Regulates Tissue Damage by Rheumatoid Arthritis Synovial Fibroblasts
10:30AM-12:30PM
Abstract Number: 0905
High-Throughput Proteomic Profiling of Sera as a Non-Invasive Method for Identifying Lupus Nephritis Subtypes
10:30AM-12:30PM
Abstract Number: 0894
HOXD13 Regulation of Primary Cilia in Rheumatoid Arthritis Synovial Fibroblasts: Implications for Joint-Specific Pathogenesis
10:30AM-12:30PM
Abstract Number: 0896
Identification of Immune Pathways Regulated by a Non-Coding Variant at DNASE1L3/PXK/PDHB
10:30AM-12:30PM
Abstract Number: 0887
Identification of Rare Variants in Lupus-causing Genes in a Mixed Paediatric and Adult Connective Tissue Disease Cohort
10:30AM-12:30PM
Abstract Number: 0909
Identifying Predictive Serum Soluble Mediators Signatures Specific to ANA+ at Risk of SLE Individuals with Next Generation Proteomics
10:30AM-12:30PM
Abstract Number: 0901
Intergenic Alu Elements Are Uniquely Expressed in Dermatomyositis and Correlate with Interferon Stimulated Genes
10:30AM-12:30PM
Abstract Number: 0916
Isocitrate Dehydrogenase 2 Mutations Are Associated with Autoimmune Rheumatologic Diseases in Chronic Myelomonocytic Leukemia
10:30AM-12:30PM
Abstract Number: 0912
Next-Generation Sequencing in Molecular Genetics of Adult-Onset Still’s Disease: Data from 23 Patients and Literature Review
10:30AM-12:30PM
Abstract Number: 0902
Novel Role of TYK2mechanism in SLE Pathogenesis via T Cell and B Cell Pathways
10:30AM-12:30PM
Abstract Number: 0892
Peptides from Candidate Sjögren’s Disease Autoantigens and Salivary Gland Tissue-Enriched Proteins Eluted from Human Salivary Gland HLA-DR
10:30AM-12:30PM
Abstract Number: 0890
Pervasive Inflammation Poisons Hematopoiesis and Drives Clonal Dominance in VEXAS Syndrome
10:30AM-12:30PM
Abstract Number: 0895
Procoagulant Extracellular Vesicles in Patients with Livedo Reticularis
10:30AM-12:30PM
Abstract Number: 0899
Proteomic Insights into JAK Inhibitor Therapeutic Response in Rheumatoid Arthritis
10:30AM-12:30PM
Abstract Number: 0906
Proteomic Signatures of Difficult-to-Treat Rheumatoid Arthritis: Identifying Predictive Biomarkers
10:30AM-12:30PM
Abstract Number: 0914
RAB19 and Azathioprine-Associated Pancreatic Injury in Patients Taking Azathioprine
10:30AM-12:30PM
Abstract Number: 0910
Reduced Adenosine-Mediated Regulatory Activity Exacerbated by an NT5E Loss of Function Mutation Is Linked to Tissue Inflammation and Hypertension in Systemic Lupus Erythematosus
10:30AM-12:30PM
Abstract Number: 0885
Reproducible Single Cell Annotation of Programs Underlying T-cell Subsets, Activation States, and Functions
10:30AM-12:30PM
Abstract Number: 0917
Role of Mutual Information Profile Shifts in Assessing the Pathogenicity of Mutations on Protein Functions: The Case of Pyrin Mutations in Familial Mediterranean Fever
10:30AM-12:30PM
Abstract Number: 0891
Shared and Disease-Specific Mechanisms of Autoimmunity Using Single Cell Sequencing of Peripheral Immune Cells
10:30AM-12:30PM
Abstract Number: 0913
The Association Between PTPN2 and Leukopenia in New Users of Azathioprine
10:30AM-12:30PM
Abstract Number: 0893
Uncovering Common and Distinctive Molecular Profiles Between Early and Stablished Rheumatoid Arthritis Through Integrative Multi-omics Analysis and Its Association with Disease Status and Clinical Response
10:30AM-12:30PM
Abstract Number: 0889
Unraveling the Progression of Sjögren’s Disease at the Cellular and Histological Level Using Single-cell and Spatial Transcriptomics

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology